pcDNA3.1(+)- e18 LOF
(Plasmid
#131729)
-
PurposeExpresses a loss of function mutant of an engineered variant of RAD18 ("e18")
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 131729 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1(+)
- Backbone size w/o insert (bp) 5444
- Total vector size (bp) 6821
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namee18/D221A (Loss of function mutant of RAD18 with SAP domain deleted and UBZ point mutation)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1377
-
GenBank IDGene ID: 56852
-
Entrez GeneRAD18 (a.k.a. RNF73)
- Promoter CMV
-
Tags
/ Fusion Proteins
- FLAG (N terminal on backbone)
- HA (N terminal on backbone)
Cloning Information
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer CMV Forward (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byRAD18 gene was obtained from the ORFeome v7 (ID:1782)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1(+)- e18 LOF was a gift from Alberto Ciccia (Addgene plasmid # 131729 ; http://n2t.net/addgene:131729 ; RRID:Addgene_131729) -
For your References section:
Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant. Nambiar TS, Billon P, Diedenhofen G, Hayward SB, Taglialatela A, Cai K, Huang JW, Leuzzi G, Cuella-Martin R, Palacios A, Gupta A, Egli D, Ciccia A. Nat Commun. 2019 Jul 30;10(1):3395. doi: 10.1038/s41467-019-11105-z. 10.1038/s41467-019-11105-z PubMed 31363085